Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 13 - Drugs for disorders of the urinary system
Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2007
11/01/2007WO2007122975A1 Hgf precursor protein mutant and activated form thereof
11/01/2007WO2007121807A1 Paediatric amino acid solution for parenteral nutrition
11/01/2007WO2007077510A3 Muscarinic receptor antagonists
11/01/2007WO2007072169A3 Pharmaceutical combination for the treatment of luts comprising a pde5 inhibitor and a muscarinic antagonist
11/01/2007US20070254959 Oxidizing 3-(2-methoxy-5-methylphenyl)-3-phenylpropanol to produce 3-(2-methoxy-5-methylphenyl)-3-phenylpropanal, reacting with diisopropylamine in presence of a reducing agent, removing hydroxyl protecting group to obtain for obtaining 3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropylamine
11/01/2007US20070254904 schizophrenia, emesis, anxiety and depression, irritable bowel syndrome (IBS), circadian rhythm disturbances, pre-eclampsia, nociception, neuropathic pain, pancreatitis, neurogenic inflammation, asthma, chronic obstructive pulmonary disease (COPD) and urinary incontinence
11/01/2007US20070254899 Soluble salts of thieno[2,3-d]pyrimidine derivatives
11/01/2007US20070254037 Methods and Compositions for the Treatment of Cell Proliferation
11/01/2007US20070253976 Compositions and methods comprising KLK3 of FOLH1 antigen
11/01/2007CA2650057A1 Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase
11/01/2007CA2649924A1 Inhibitors of c-fms kinase
11/01/2007CA2649800A1 Hgf precursor protein variant and active protein thereof
11/01/2007CA2649739A1 Inhibitors of c-fms kinase
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2647087A1 Paediatric amino acid solution for parenteral nutrition
10/2007
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1848427A1 Use of estrogen receptor-b selective agonists for radiation-or chemotherapy-induced mucosistis and radiation cystitis
10/31/2007EP1368301B1 Side-chain halogenated amino carboxylic acid derivatives as medicaments for treating cardiovascular diseases
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007CN101065124A Medicinal composition for prevention of transition to operative treatment for prostatic hypertrophy
10/31/2007CN101065119A Ameliorant for renal insufficiency
10/31/2007CN101063161A Coproduction technique for collagen and chondroitin sulfate
10/31/2007CN101062404A Pidotimod injection and the producing method thereof
10/31/2007CN101062381A Health-care food for supplementing kidney and strengthening Yang and its preparing process
10/31/2007CN101062356A Chinese traditional medicine for treating children's enuresis
10/31/2007CN101062334A Wine good for kidney
10/31/2007CN101062325A Granule good for liver and kidney
10/31/2007CN101062305A Cortex lycii radicis decoction
10/31/2007CN101062298A Health-care food for improving stranguria symptoms and the preparing method thereof
10/31/2007CN101062250A Function of anemarrhena extract for preparing medicine of treating prostatic hyperplasia
10/31/2007CN101062249A Combination of anemarrhena extract and phellodendron extract and the function thereof
10/31/2007CN101062245A Chinese traditional medicine agent for treating children nephropathy syndrome
10/31/2007CN101062244A Liquid medicine for treating lithiasis
10/31/2007CN101062232A Granule for strengthening kidney
10/31/2007CN101062231A Pill of medlar and rehmannia
10/31/2007CN101062193A Health-care wine for invigorating kidney and strengthening body
10/31/2007CN101062168A Chinese traditional combination for treating chronic nephritis
10/31/2007CN101062160A Draba pills for treating asthma
10/31/2007CN101062139A Ointment for removing toxin
10/31/2007CN101062083A Processing method for reducing the poison of triptolide and the corresponding preparation
10/31/2007CN101062055A Slowly-released type nanometer silver antibacterial gel and the preparing method and the application thereof
10/31/2007CN101061865A Method of producing ten-sapor tuckahoe sesame powder
10/31/2007CN101061840A Method of producing black bean ball having functions of strengthening kidney and bone
10/31/2007CN100345866C Compound for unstable dipeptidyl peptidase IV inhibitors
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
10/31/2007CN100345840C Stable hydrate of a muscarinic receptor antagonist
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345829C Pyrimidyl sulphone amide derivatives as chemokine receptor modulators
10/31/2007CN100345593C Remedy or preventive for kidney disease and method of diagnosing kidney disease
10/31/2007CN100345549C Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
10/31/2007CN100345547C Method of treating prostatic disease using delayed and/or sustained release vitamin D formulations
10/31/2007CN100345545C 6-amino-ª‡(R)-hydroxyl-9H-purin-9-ethyl butyrate immunological suppression effect
10/31/2007CN100345492C Method for preparing kidney-benefiting, fatigue-reducing soybean milk sheet with micron pilose antler, safflower, cactus, dodder powder
10/30/2007US7288654 7,8,9,10-Tetrahydropyrido[2,3-b]azocine derivatives; CCR5 chemokine receptor antagonists; prophylactic for lymphadenopathy associated and/or human T-cell leukemia/lymphoma virus infections in peripheral mononuclear blood cells; AIDS; quaternization, oxidation, condensation, deprotecting, amidation
10/30/2007US7288650 Protein kinase inhibitors; anticarcinogenic agents; benign prostatic hyperplasia
10/30/2007US7288566 Inhibit 20-hydroxyeicosatetraenoic acid (20-HETE)-producing enzymes; kidney disease
10/30/2007US7288558 Pharmaceutical composition for treatment for urinary diseases comprising LPA receptor regulator
10/30/2007US7288519 Exocyclic peptide having amino acid sequence of a Fas surface domain; antagonists of the Fas receptor (Fas)-Fas ligand complex
10/30/2007US7288251 Antibodies to CD40
10/30/2007CA2509650C C-6 modified indazolylpyrrolotriazines
10/30/2007CA2451433C Oligopeptide transporter 1 inhibitor
10/25/2007WO2007120445A1 SOLUBLE SALTS OF THIENO [2,3-d] PYRIMIDINE DERIVATIVES
10/25/2007WO2007119684A1 Spraying agent
10/25/2007WO2007119656A1 Tamsulosin-containing percutaneous absorption type preparation
10/25/2007WO2007119367A1 Composition containing biopterin and method for using the same
10/25/2007WO2007119110A2 Process for the preparation of tamsulosin and related compounds
10/25/2007WO2007070393A3 Mglur1 anatgonists as therapeutic agents
10/25/2007WO2007039909A3 Compositions and methods for treatment of renal failure
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249729 Method of Treating Elevated Plasma Homocysteine Levels in Esrd Patients
10/25/2007US20070249720 Thiourea Derivative-Containing Pharmaceutical Composition Having Improved Solubility and Bioavailability
10/25/2007US20070249719 Compounds for the treatment of metabolic disorders
10/25/2007US20070249703 (Hydroxyphenyl)-1H-Indole-3-Carbaldehyde Oxime Derivatives As Estrogenic Agents
10/25/2007US20070249696 Compounds for the treatment of metabolic disorders
10/25/2007US20070249682 Novel CD40:CD154 binding interruptor compounds and use thereof to treat immunological complications
10/25/2007US20070249676 Cyanoguanidine prodrugs
10/25/2007US20070249659 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide
10/25/2007US20070249653 Tetracyclic benzamide derivatives and methods of use thereof
10/25/2007US20070249638 Derivatives of triazoly-imidazopyridine and of the triazolypurines useful as ligands of the adenosine A2a receptor and their use as medicaments
10/25/2007US20070249604 3-Monosubstituted tropane derivatives as nociceptin receptor ligands
10/25/2007US20070248639 Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological procedures
10/25/2007CA2627133A1 Process for the preparation of tamsulosin and related compounds
10/24/2007EP1847620A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
10/24/2007EP1847550A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/24/2007EP1847541A1 Fused pyrimidine derivative and uses thereof
10/24/2007EP1847535A1 1-(piperidin-4-yl)-1h-indole derivative
10/24/2007EP1847271A2 Water-absorbent polymers and their use as a medicament
10/24/2007EP1847265A1 The use of flavonol and flavonol glycosides for stimulating growth of renal tubular epithelial cells to secrete the kidney secreting bone growth factor
10/24/2007EP1846386A2 Novel coumarin derivatives as ion channel openers
10/24/2007EP1846366A1 Norvaline derivative and method for preparation thereof
10/24/2007EP1846106A1 Pharmaceutical composition for treating nephropathy and healthy food comprising herb extracts
10/24/2007EP1846005A2 Kits and improved compositions for treating lower urinary tract
10/24/2007EP1845999A1 Use of a fatty acid composition containing dha for the production of a medical product or a food stuff for the treatment of amyloidos-rerelated diseases
10/24/2007EP1845963A2 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma
10/24/2007EP1606307B1 Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/24/2007EP1424334B1 Quinazolinone derivative
10/24/2007EP1207860B1 Controlled release pellet formulation
1 ... 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 ... 562